GlassScriptPhysician profile
Elina Pales
NPI 1386746949
$5,594.38
in general payments reported to CMS, 2019-2025
51 companies · $444 in 2025
The $444 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $592 · 2020: $852 · 2021: $929 · 2022: $1,051 · 2023: $817 · 2024: $909 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,170.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $528.83 | 2021-2025 | |
| Ucb, INC. | $417.96 | 2019-2024 | Rystiggo, Zilbrysq |
| Novartis Pharmaceuticals Corporation | $341.41 | 2019-2022 | |
| Genzyme Corporation | $331.77 | 2019-2023 | |
| Lundbeck LLC | $280.50 | 2022-2025 | Vyepti |
| Janssen Pharmaceuticals, INC | $272.54 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $266.45 | 2019-2025 | Austedo Xr, Austedo Xr |
| Neurocrine Biosciences, INC. | $255.49 | 2019-2024 | Ingrezza |
| Argenx US, INC. | $236.06 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Celgene Corporation | $220.82 | 2021-2023 | Zeposia |
| Amneal Pharmaceuticals LLC | $218.23 | 2019-2024 | Rytary |
| Lilly USA, LLC | $213.68 | 2019-2025 | Reyvow, Emgality, Kisunla |
| Alexion Pharmaceuticals, INC. | $213.67 | 2019-2023 | Ultomiris |
| Pfizer INC. | $178.37 | 2023-2025 | |
| Mdd US Operations, LLC | $139.78 | 2019-2024 | Gocovri, Gocovri |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elina Pales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.